Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPLP0P12 is a processed pseudogene in the human genome, corresponding to the ribosomal protein lateral stalk subunit P0 gene. While the functional parental gene RPLP0 encodes a protein of the ribosomal 60S subunit[1][3][5], RPLP0P12 itself does not produce a protein. This pseudogene may have potential non-coding regulatory roles by influencing gene expression, as some pseudogenes do, but there are no specific functional, disease, or therapeutic associations currently documented for RPLP0P12[9][10][2][4][6]. Its canonical genomic name is Ribosomal protein lateral stalk subunit P0 pseudogene 12, abbreviated RPLP0P12, and it should not be confused with the functional ribosomal protein Lateral Stalk Subunit P0 (RPLP0), which is associated with ribosome function and diseases like Diamond-Blackfan Anemia[1][5]. If you need information on the actual therapeutic target (RPLP0—the protein), specify "ribosomal protein lateral stalk subunit P0" rather than "pseudogene 12". RPLP0P12 is a non-coding pseudogene and not a drug target.
Not applicable; pseudogenes do not produce protein and have no direct mechanism targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P0 pseudogene 12 (RPLP0P12).